VASH1 and neuroendocrine carcinoma: In the high CD163 expression group, VASH-1 density and immunoreactivity were greater in the NEC than in the non-NEC components in both intra-tumoral areas and invasive margins, but the difference was not statistically significant (Figure 7a,b).